Ingevity Corporation Stock News

Q1 2020 Ingevity Corp Earnings Call

Ingevity (NGVT) expects sales for 2020 to be between $1.1 billion and $1.2 billion.

Ingevity (NGVT) expects sales for 2020 to be between $1.1 billion and $1.2 billion.

Oppenheimer analyst Ian Zaffino maintained a Buy rating on Ingevity (NGVT) today and set a price target of $65.00. The company's shares closed last

Ingevity Corporation (NGVT) delivered earnings and revenue surprises of 33.33% and 9.99%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Ingevity Corporation (NGVT) delivered earnings and revenue surprises of 33.33% and 9.99%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Ingevity (NYSE:NGVT) reported first quarter net sales of $288.2M, representing an increase of 4.1% versus $276.8M in the prior year's first quarter.

Fly Intel: After-Hours Movers ET PTON RIG HIG INOV EBAY AFL QCOM MSFT PS VRTX HCC NGVT TSLA NOW HOLX FB MTSI UCTT AR MTDR CCS KRA

Ardevora Asset Management LLP lifted its holdings in Ingevity Corp (NYSE:NGVT) by 91.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The

Ingevity (NYSE:NGVT) is set to announce its earnings results after the market closes on Wednesday, April 29th. Analysts expect the company to announce earnings of $0.84 per share for the quarter. Inge

Ingevity Corp (NYSE:NGVT) – Equities researchers at SunTrust Banks lowered their Q3 2020 earnings per share (EPS) estimates for shares of Ingevity in a research report issued on Monday, April 20th.

Ingevity Corporation (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ingevity Corporation (NGVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ingevity (NYSE:NGVT) had its price target dropped by stock analysts at BMO Capital Markets from $111.00 to $74.00 in a research note issued to investors on Monday, The Fly reports. The firm presently

Ingevity Corp (NYSE:NGVT) saw a large decline in short interest during the month of March. As of March 31st, there was short interest totalling 1,490,000 shares, a decline of 12.9% from the March 15th